Summary of Study ST003326
This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR002068. The data can be accessed directly via it's Project DOI: 10.21228/M89F9K This work is supported by NIH grant, U2C- DK119886.
See: https://www.metabolomicsworkbench.org/about/howtocite.php
This study contains a large results data set and is not available in the mwTab file. It is only available for download via FTP as data file(s) here.
| Study ID | ST003326 |
| Study Title | Lipidome profiling in non-alcoholic steatohepatitis identifies phosphatidylserine synthase 1 as a regulator of hepatic lipoprotein metabolism |
| Study Summary | Non-alcoholic fatty liver disease and more progressive non-alcoholic steatohepatitis (NASH) are characterized by defective lipid metabolism, which causes hepatic steatosis and disease progression. However, the changes in lipid metabolism in NASH are incompletely understood. Using lipidome profiling in livers of eight mouse strains, that differ substantially in susceptibility to NASH and liver fibrosis, as well as in patients with NASH, we show that phosphatidylserine (PS) accumulation and preservation of PS synthase 1 (PSS1) expression is associated with resistance to NASH. Mechanistically, PSS1 overexpression in the liver reduces hepatic steatosis through remodeling of the hepatic and liver-derived VLDL lipidome in mice with NASH. Specifically, we show an increase in VLDL ceramide content that suppresses the expression and activity of lipoprotein lipase (LPL) in skeletal muscle, thereby reducing VLDL-triglyceride clearance, fatty acid uptake and lipid accumulation in skeletal muscle. In addition, remodelling of lipoprotein composition inhibits the LDL receptor in the liver, likely contributing to the reduction in hepatic steatosis. Together, this study provides a unique resource describing lipidome changes in NASH, and identifies PSS1 as a novel regulator of hepatic lipoprotein metabolism. |
| Institute | University of Melbourne |
| Last Name | Montgomery |
| First Name | Magdalene |
| Address | Corner Grattan Street & Royal Parade |
| magdalene.montgomery@unimelb.edu.au | |
| Phone | 0422059907 |
| Submit Date | 2024-05-13 |
| Raw Data Available | Yes |
| Raw Data File Type(s) | abf |
| Analysis Type Detail | LC-MS |
| Release Date | 2024-10-21 |
| Release Version | 1 |
Select appropriate tab below to view additional metadata details:
Project:
| Project ID: | PR002068 |
| Project DOI: | doi: 10.21228/M89F9K |
| Project Title: | Lipidome profiling in non-alcoholic steatohepatitis identifies phosphatidylserine synthase 1 as a regulator of hepatic lipoprotein metabolism |
| Project Summary: | This project aimed to investigate the regulation of the hepatic lipidome in mice with non-alcoholic steatohepatitis (NASH) and liver fibrosis, and assess the differences in the hepatic lipidome in mouse strains susceptible or resistant to NASH and metabolic comorbidities. For this purpose, eight mouse strains were fed either a chow control diet or a western-style diet enriched in lipid, carbohydrate and cholesterol for 30-32 weeks, followed by in-depth metabolic phenotyping, assessment of liver pathology and the hepatic lipidome by LC/MS. This study found that resistance to diet-induced NASH in BALB/c mice was associated with increased hepatic phosphatidylserine (PS) content. Subsequent studies focusing on overexpression of PS synthase 1 (PSS1) in the livers of mice with steatosis or NASH show that increasing hepatic PS is associated with improvements in steatosis and/or inflammation. |
| Institute: | University of Melbourne |
| Last Name: | Montgomery |
| First Name: | Magdalene |
| Address: | Corner Grattan Street Royal Parade, Melbourne, Victoria, 3010, Australia |
| Email: | magdalene.montgomery@unimelb.edu.au |
| Phone: | 0422059907 |
Subject:
| Subject ID: | SU003447 |
| Subject Type: | Mammal |
| Subject Species: | Mus musculus |
| Taxonomy ID: | 10090 |
| Genotype Strain: | A/J, BALB/c, C3H/HeJ, C57BL/6J, CBA/CaH, DBA/2J, FVB/NJ and NOD/ShiLtJ mice |
| Age Or Age Range: | Mice were fed a low-fat or western-style diet for 30-32 weeks |
| Weight Or Weight Range: | 30-45 grams |
| Gender: | Male |
| Animal Animal Supplier: | Animal Resources Centre, Canning Vale, Australia |
| Animal Housing: | Group housing (3-5 mice/cage) |
| Animal Light Cycle: | 12/12 light/dark |
| Animal Feed: | low-fat chow or high-fat high-sugar high-cholesterol diet (SF16-033 Specialty Feeds, Australia) |
| Animal Water: | ad libitum water |
| Species Group: | Mammals |
Factors:
Subject type: Mammal; Subject species: Mus musculus (Factor headings shown in green)
| mb_sample_id | local_sample_id | Mouse Strain | Food source | Sample source |
|---|---|---|---|---|
| SA361345 | 210226_Hamze_MM-1835_055p | A/J | Chow | Liver |
| SA361346 | 210226_Hamze_MM-1835_051n | A/J | Chow | Liver |
| SA361347 | 210226_Hamze_MM-1835_053n | A/J | Chow | Liver |
| SA361348 | 210226_Hamze_MM-1835_055n | A/J | Chow | Liver |
| SA361349 | 210226_Hamze_MM-1835_057n | A/J | Chow | Liver |
| SA361350 | 210226_Hamze_MM-1835_059n | A/J | Chow | Liver |
| SA361351 | 210226_Hamze_MM-1835_061n | A/J | Chow | Liver |
| SA361352 | 210226_Hamze_MM-1835_063n | A/J | Chow | Liver |
| SA361353 | 210226_Hamze_MM-1835_065n | A/J | Chow | Liver |
| SA361354 | 210226_Hamze_MM-1835_067n | A/J | Chow | Liver |
| SA361355 | 210226_Hamze_MM-1835_068n | A/J | Chow | Liver |
| SA361356 | 210226_Hamze_MM-1835_053p | A/J | Chow | Liver |
| SA361357 | 210226_Hamze_MM-1835_051p | A/J | Chow | Liver |
| SA361358 | 210226_Hamze_MM-1835_068p | A/J | Chow | Liver |
| SA361359 | 210226_Hamze_MM-1835_067p | A/J | Chow | Liver |
| SA361360 | 210226_Hamze_MM-1835_059p | A/J | Chow | Liver |
| SA361361 | 210226_Hamze_MM-1835_061p | A/J | Chow | Liver |
| SA361362 | 210226_Hamze_MM-1835_065p | A/J | Chow | Liver |
| SA361363 | 210226_Hamze_MM-1835_057p | A/J | Chow | Liver |
| SA361364 | 210226_Hamze_MM-1835_063p | A/J | Chow | Liver |
| SA361365 | 210226_Hamze_MM-1835_056p | A/J | NASH | Liver |
| SA361366 | 210226_Hamze_MM-1835_064p | A/J | NASH | Liver |
| SA361367 | 210226_Hamze_MM-1835_052n | A/J | NASH | Liver |
| SA361368 | 210226_Hamze_MM-1835_054n | A/J | NASH | Liver |
| SA361369 | 210226_Hamze_MM-1835_066p | A/J | NASH | Liver |
| SA361370 | 210226_Hamze_MM-1835_056n | A/J | NASH | Liver |
| SA361371 | 210226_Hamze_MM-1835_058n | A/J | NASH | Liver |
| SA361372 | 210226_Hamze_MM-1835_062n | A/J | NASH | Liver |
| SA361373 | 210226_Hamze_MM-1835_060n | A/J | NASH | Liver |
| SA361374 | 210226_Hamze_MM-1835_062p | A/J | NASH | Liver |
| SA361375 | 210226_Hamze_MM-1835_064n | A/J | NASH | Liver |
| SA361376 | 210226_Hamze_MM-1835_066n | A/J | NASH | Liver |
| SA361377 | 210226_Hamze_MM-1835_060p | A/J | NASH | Liver |
| SA361378 | 210226_Hamze_MM-1835_052p | A/J | NASH | Liver |
| SA361379 | 210226_Hamze_MM-1835_058p | A/J | NASH | Liver |
| SA361380 | 210226_Hamze_MM-1835_054p | A/J | NASH | Liver |
| SA361381 | 210226_Hamze_MM-1835_030p | BALBc | Chow | Liver |
| SA361382 | 210226_Hamze_MM-1835_029p | BALBc | Chow | Liver |
| SA361383 | 210226_Hamze_MM-1835_034p | BALBc | Chow | Liver |
| SA361384 | 210226_Hamze_MM-1835_033p | BALBc | Chow | Liver |
| SA361385 | 210226_Hamze_MM-1835_037p | BALBc | Chow | Liver |
| SA361386 | 210226_Hamze_MM-1835_029n | BALBc | Chow | Liver |
| SA361387 | 210226_Hamze_MM-1835_030n | BALBc | Chow | Liver |
| SA361388 | 210226_Hamze_MM-1835_033n | BALBc | Chow | Liver |
| SA361389 | 210226_Hamze_MM-1835_034n | BALBc | Chow | Liver |
| SA361390 | 210226_Hamze_MM-1835_035n | BALBc | Chow | Liver |
| SA361391 | 210226_Hamze_MM-1835_036n | BALBc | Chow | Liver |
| SA361392 | 210226_Hamze_MM-1835_037n | BALBc | Chow | Liver |
| SA361393 | 210226_Hamze_MM-1835_036p | BALBc | Chow | Liver |
| SA361394 | 210226_Hamze_MM-1835_035p | BALBc | Chow | Liver |
| SA361395 | 210226_Hamze_MM-1835_026n | BALBc | NASH | Liver |
| SA361396 | 210226_Hamze_MM-1835_024n | BALBc | NASH | Liver |
| SA361397 | 210226_Hamze_MM-1835_023n | BALBc | NASH | Liver |
| SA361398 | 210226_Hamze_MM-1835_022n | BALBc | NASH | Liver |
| SA361399 | 210226_Hamze_MM-1835_021n | BALBc | NASH | Liver |
| SA361400 | 210226_Hamze_MM-1835_022p | BALBc | NASH | Liver |
| SA361401 | 210226_Hamze_MM-1835_021p | BALBc | NASH | Liver |
| SA361402 | 210226_Hamze_MM-1835_025n | BALBc | NASH | Liver |
| SA361403 | 210226_Hamze_MM-1835_028n | BALBc | NASH | Liver |
| SA361404 | 210226_Hamze_MM-1835_027n | BALBc | NASH | Liver |
| SA361405 | 210226_Hamze_MM-1835_023p | BALBc | NASH | Liver |
| SA361406 | 210226_Hamze_MM-1835_024p | BALBc | NASH | Liver |
| SA361407 | 210226_Hamze_MM-1835_025p | BALBc | NASH | Liver |
| SA361408 | 210226_Hamze_MM-1835_026p | BALBc | NASH | Liver |
| SA361409 | 210226_Hamze_MM-1835_027p | BALBc | NASH | Liver |
| SA361410 | 210226_Hamze_MM-1835_028p | BALBc | NASH | Liver |
| SA361411 | 210226_Hamze_MM-1835_006p | BL6 | Chow | Liver |
| SA361412 | 210226_Hamze_MM-1835_003p | BL6 | Chow | Liver |
| SA361413 | 210226_Hamze_MM-1835_004p | BL6 | Chow | Liver |
| SA361414 | 210226_Hamze_MM-1835_005p | BL6 | Chow | Liver |
| SA361415 | 210226_Hamze_MM-1835_010p | BL6 | Chow | Liver |
| SA361416 | 210226_Hamze_MM-1835_007p | BL6 | Chow | Liver |
| SA361417 | 210226_Hamze_MM-1835_008p | BL6 | Chow | Liver |
| SA361418 | 210226_Hamze_MM-1835_009p | BL6 | Chow | Liver |
| SA361419 | 210226_Hamze_MM-1835_002n | BL6 | Chow | Liver |
| SA361420 | 210226_Hamze_MM-1835_002p | BL6 | Chow | Liver |
| SA361421 | 210226_Hamze_MM-1835_001n | BL6 | Chow | Liver |
| SA361422 | 210226_Hamze_MM-1835_001p | BL6 | Chow | Liver |
| SA361423 | 210226_Hamze_MM-1835_007n | BL6 | Chow | Liver |
| SA361424 | 210226_Hamze_MM-1835_009n | BL6 | Chow | Liver |
| SA361425 | 210226_Hamze_MM-1835_008n | BL6 | Chow | Liver |
| SA361426 | 210226_Hamze_MM-1835_010n | BL6 | Chow | Liver |
| SA361427 | 210226_Hamze_MM-1835_006n | BL6 | Chow | Liver |
| SA361428 | 210226_Hamze_MM-1835_005n | BL6 | Chow | Liver |
| SA361429 | 210226_Hamze_MM-1835_004n | BL6 | Chow | Liver |
| SA361430 | 210226_Hamze_MM-1835_003n | BL6 | Chow | Liver |
| SA361431 | 210226_Hamze_MM-1835_011p | BL6 | NASH | Liver |
| SA361432 | 210226_Hamze_MM-1835_013p | BL6 | NASH | Liver |
| SA361433 | 210226_Hamze_MM-1835_014p | BL6 | NASH | Liver |
| SA361434 | 210226_Hamze_MM-1835_015p | BL6 | NASH | Liver |
| SA361435 | 210226_Hamze_MM-1835_016p | BL6 | NASH | Liver |
| SA361436 | 210226_Hamze_MM-1835_017p | BL6 | NASH | Liver |
| SA361437 | 210226_Hamze_MM-1835_018p | BL6 | NASH | Liver |
| SA361438 | 210226_Hamze_MM-1835_019p | BL6 | NASH | Liver |
| SA361439 | 210226_Hamze_MM-1835_020p | BL6 | NASH | Liver |
| SA361440 | 210226_Hamze_MM-1835_012p | BL6 | NASH | Liver |
| SA361441 | 210226_Hamze_MM-1835_020n | BL6 | NASH | Liver |
| SA361442 | 210226_Hamze_MM-1835_011n | BL6 | NASH | Liver |
| SA361443 | 210226_Hamze_MM-1835_012n | BL6 | NASH | Liver |
| SA361444 | 210226_Hamze_MM-1835_013n | BL6 | NASH | Liver |
Collection:
| Collection ID: | CO003440 |
| Collection Summary: | This collection contains data on the liver lipidome across 8 inbred mouse strains fed either a chow control diet or a western-style diet enriched in lipid, carbohydrate and cholesterol. Untargeted lipidomics data available from 144 mice across eight mouse strains and two dietary regimes. |
| Sample Type: | Liver |
Treatment:
| Treatment ID: | TR003456 |
| Treatment Summary: | For the assessment of mouse strain-dependent variation in the hepatic lipidome, eight-week-old male A/J, BALB/c, C3H/HeJ, C57BL/6J, CBA/CaH, DBA/2J, FVB/NJ and NOD/ShiLtJ mice (Animal Resources Centre, Canning Vale, Australia) were fed either a rodent chow diet (5% energy from fat) or a diet enriched in fat (40% energy from lard), carbohydrate (40% energy from carbohydrates, of this 20% fructose), and 2% cholesterol (SF16-033 Specialty Feeds, Australia) for a total of 30-32 weeks (referred to as NASH diet). |
Sample Preparation:
| Sampleprep ID: | SP003454 |
| Sampleprep Summary: | Lipids from whole liver were extracted using a monophasic extraction protocol. Briefly, 5-10 mg of liver was homogenized using a Precellys tissue homogenizer in 100 µL 1:1 butanol-methanol, containing 5 µL of SPLASH® II LIPIDOMIX® Mass Spec Standard (part no. 330709W, Avanti Polar Lipids Inc) and 5 uL of Ceramide LIPIDOMIX® Mass Spec Standard (part no. 330712X, Avanti Polar Lipids Inc). Samples were mixed for 1 h at room temperature, centrifuged (14,000 g, 10 min, 20 ⁰C) and transferred into sample vials with glass inserts for analysis. |
Chromatography:
| Chromatography ID: | CH004136 |
| Instrument Name: | Thermo Vanquish |
| Column Name: | Agilent ZORBAX Eclipse Plus C18 (100 x 2.1mm,1.8um) |
| Column Temperature: | 60 |
| Flow Gradient: | a flow rate of 350 uL/min for 3 min using 30% solvent B. During separation, the percentage of solvent B was increased from 30% to 70% in 5 min, from 70% to 93% in 9 min and, from 93% to 99% in 7 min, and from 91% to 97% in 31 min. Subsequently, the percentage of solvent B was increased to 99.5% in 0.1 min and then maintained at 99.5% for 3 min. Finally, the percentage of solvent B was decreased to 30% in 0.1 min and maintained for 3.9 min |
| Flow Rate: | 350 uL/min |
| Solvent A: | 60% Acetonitrile/40% Water; 10 mM ammonium acetate; 5 uM medronic acid |
| Solvent B: | 90% Isopropanol/10% Acetonitrile; 10 mM ammonium acetate |
| Chromatography Type: | Reversed phase |
Analysis:
| Analysis ID: | AN005448 |
| Analysis Type: | MS |
| Chromatography ID: | CH004136 |
| Num Factors: | 17 |
| Num Metabolites: | 678 |
| Units: | pmol/mg tissue |
| Analysis ID: | AN005449 |
| Analysis Type: | MS |
| Chromatography ID: | CH004136 |
| Num Factors: | 17 |
| Num Metabolites: | 829 |
| Units: | pmol/mg tissue |